COVAX vaccine 2021 delivery target cut to 1.425 billion doses
Reasons for the cut include export restrictions on key supplier Serum Institute of India (SII), Gavi said in a joint statement with the Coalition for Epidemic Preparedness Innovations (CEPI), the World Health Organization and Unicef
A nurse prepares to administer the AstraZeneca/Oxford vaccine under the COVAX scheme against the coronavirus disease (Covid-19) at the Eka Kotebe General Hospital in Addis Ababa, Ethiopia March 13, 2021. REUTERS/Tiksa Negeri/File Photo
The COVAX vaccine-sharing facility will likely receive 1.425 billion doses of anti-Covid-19 shots from donor countries this year, down from a July estimate of 2 billion, the GAVI Vaccine Alliance said on Wednesday.
Reasons for the cut include export restrictions on key supplier Serum Institute of India (SII), Gavi said in a joint statement with the Coalition for Epidemic Preparedness Innovations (CEPI), the World Health Organization and Unicef.
Manufacturing problems at Johnson & Johnson and AstraZeneca as well as delays in the regulatory review of shots developed by US biotech firm Novavax and China's Clover Biopharmaceuticals were further limiting factors, the organisations said.
Keep updated, follow The Business Standard's Google news channel
